Modulators of Nucleoside Metabolism in the Therapy of Brain Diseases

E-ISSN： 1873-4294|11|8|1068-1086

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.8, 2011-04, pp. : 1068-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis modulators in the therapy of neurodegenerative diseases

By Deigner H-P. Haberkorn U. Kinscherf R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 747-764

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Ischemic Brain Diseases

Current Gene Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 49-58

Bentham Science Publishers

Access to resources Recommend Favorite

Gemcitabine: A Critical Nucleoside for Cancer Therapy

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 1076-1087

Bentham Science Publishers

Access to resources Recommend Favorite

Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 3, 2013-03 ,pp. : 313-330

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction of Nucleoside Analogues with Nucleoside Transporters in Rat Brain Endothelial Cells

By Chishty Mansoor Begley David J. Abbott N. Joan Reichel Andreas

Journal of Drug Targeting, Vol. 12, Iss. 5, 2004-06 ,pp. : 265-272

Informa Healthcare

Access to resources Recommend Favorite